The PurpleLab® Resource Center

Featured Resources

Life Sciences

More than a year has passed since Humira biosimilars were launched in the US, and with these, several other biosimilar drug approvals that either directly compete with Humira or are indicated for other rare immunologic conditions, macular degeneration, and oncology and hematological disease.  Ongoing industry surveillance of biosimilars and the   Source: “Biosimilars are becoming more widely available,…

Life Sciences

Learn more about what PurpleLab can do for Commercial Pharma Life Sciences Download

With celebrity endorsements of drugs from GLP-1s to migraine medications, pharmaceutical advertisers are embracing high-profile celebrity marketing. But in the age of social media, you don’t have to be a celebrity to have influence.

Get In Touch

Questions? Ready for a demo or free trial of our healthcare analytics platform, HealthNexus™?
Contact us to get started.